$41.42
-0.84-1.99%
Pre-Market: Jul 18, 4:00 PM EDT
15 minutes delayed
Comments
Loading...
Neurogene
NGNENASDAQ
Neurogene (NASDAQ:NGNE) Stock Quotes, Forecast and News Summary
Neurogene Stock (NASDAQ: NGNE) stock price, news, charts, stock research, profile.
| Open | - |
| Close | - |
| Volume / Avg. | 0 / 115.77K |
| Day Range | - - - |
| 52 Wk Range | 12.49 - 53.00 |
| Market Cap | $537.64M |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 55 |
| Short Interest | 9.22% |
| Days to Cover | 3.66 |
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About Neurogene Inc
Sector
Health Care
Industry
Biotechnology
Neurogene Inc is a clinical stage biotechnology company whose objective is to harness the power of g...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Neurogene (NGNE) stock?
You can purchase shares of Neurogene (NASDAQ:NGNE) through any online brokerage.
Who are Neurogene (NGNE) competitors?
Other companies in Neurogene’s space includes: Valneva (NASDAQ:VALN), Voyager Therapeutics (NASDAQ:VYGR), Larimar Therapeutics (NASDAQ:LRMR), PepGen (NASDAQ:PEPG) and Pharming (NASDAQ:PHAR).
What is the target price for Neurogene (NGNE) stock?
There is no analysis for Neurogene.
What is the forecast for Neurogene (NGNE) stock?
Neurogene has a consensus price target of $49.40.
Current stock price for Neurogene (NGNE)?
The stock price for Neurogene (NASDAQ: NGNE) is $41.42 last updated July 18, 2024 at 4:00 PM EDT.
Does Neurogene (NGNE) pay a dividend?
There are no upcoming dividends for Neurogene.
When is Neurogene (NASDAQ:NGNE) reporting earnings?
Neurogene’s Q2 earnings are confirmed for Thursday, August 15, 2024.
Is Neurogene (NGNE) going to split?
There is no upcoming split for Neurogene.
What sector and industry does Neurogene (NGNE) operate in?
Neurogene is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.